Board Member Profile

Board Members
Director, Audit & Supervisory Committee Member
CTO Executive Officer CTO
Advisors

Board Members

Takuya YOKOKAWA
President ＆CEO, Executive Officer
Date of birth: Oct. 13, 1960

Career

Apr. 1985	Joined Fuji Photo Film Co., Ltd. (currently FUJIFILM Corp.(FUJIFILM))
Oct. 1996	Manager, Ashigara Research Laboratories, FUJIFILM
Apr. 2004	Senior manager, Research and Development Management HQ, Digital & Photo Imaging Material Research Laboratories, FUJIFILM
Jun. 2007	Deputy General Manager, life science Research Laboratories, Research and Development Management HQ / Senior Manager, Business Development Office Life Science Business Division, FUJIFILM
Jul. 2008	Toyama Chemical Co., Ltd. (currently FUJIFILM Toyama Chemical Co., Ltd.)　on loan
Jun. 2009	General Manager, Drug Discovery Research Laboratories, Research and Development Management HQ, FUJIFILM
Sep. 2013	General Manager, Regenerative Medicine Business Development Office/Deputy General Manager, Pharmaceutical Products. Div., FUJIFILM
Apr. 2015	Manager, Regenerative Medicine Business Development Office, FUJIFILM /　Forum for Innovative Regenerative Medicine,　on loan
Dec. 2017	Manager, Healthcare Business Development Office, FUJIFILM
Mar. 2018	Director, Perseus Proteomics Inc. (the Company)
Jun. 2018	President & CEO, the Company (to present)
Jan. 2019	Executive Officer, the Company (to present)

Shinichi SUZUKAWA
Director, Executive Officer, Head of Administrative Dept.,
Date of birth: Sep. 20, 1955

Career

Apr. 1978	Joined Kokusai Denshin Denwa Co. Ltd. (currently KDDI CORPORATION）
Jul. 1996	Vice President, KDD Europe (currently KDDI Europe)
Feb. 2002	President, Telehouse Europe
Apr. 2005	Network Solution KANSAI Regional Office, KDDI CORPORATION (KDDI)
Apr. 2008	Regional Executive Officer, Asia Pacific/President, KDDI Singapore
Jan. 2010	Vice Chairman, DMX Technologies Group LTD
Jan. 2013	Executive Director, Global ICT Business Division, Global Business Sector, KDDI
Jun. 2016	Statutory Auditor, KDDI Evolva, Inc. (currently Altius Link, Inc.)
Sep. 2018	Outside Director, ACSL Ltd.
Jun. 2019	Statutory Auditor, the Company
Jun. 2020	Director, Executive Officer & Head of Administrative Dept.,the Company (to present)

Shinji HAGIWARA
Director, Executive Officer, Head of R&D Dept., Head of Business Development Dept.
Date of birth: Mar. 23, 1965

Career

Apr. 1989	Sandoz Yakuhin K.K.
May 2001	Team Leader, Biosciences Department, GlaxoSmithKline K.K.
Feb. 2007	Research Manager, life science Research Laboratories, Research & Development Management HQ, FUJIFILM Corporation
Oct. 2013	Senior Manager, Pharmaceutical & Healthcare Research Laboratories, Research & Development Management HQ, FUJIFILM Corporation
Nov. 2021	Head of Business Development Dept. (to present) & Deputy Head of Research and Development Dept., the Company
Jun. 2022	Executive Officer & Head of Research and Developmenet Dept., the Company (to present)
Jun. 2023	Director, the Company (to present)

Kinichiro KOMINAMI
Outside Director
Date of birth: Jan. 20, 1967

Career

Jul. 1994	PhD, Researcher, Imperial Cancer Research Fund Laboratories
Sep. 1998	Assistant Professor, Medical Institute of Bioregulation, Kyushu University
Jun. 2001	Joined Nomura Securities, Co., Ltd. (Nomura Securities) Nomura Research and Advisory Co., Ltd. (NRA) on loan
Jun. 2011	Executive Director, Investment Dept. NRA
Apr. 2013	Section Chief, Regional Financial Institutional and Public Sector Clients Consulting Dept., Nomura Securities
Aug. 2015	Director, Corporate Business Group, Mizuho Securities, Co., Ltd.
Sep. 2017	President & CEO, Tech & FinStrategy Inc. (to present)
Oct. 2017	Outside Director, Cellspect Co., Ltd. (to present)
Jun. 2018	Director, the Company (to present) Outside Director, Delta-Fly Pharma, Inc. (to present)
Aug. 2019	Outside Director, Veritas In Silico Inc. (to present)
Aug. 2021	Outside Director, EGAIA Co., Ltd. (to present)
Dec. 2021	Outside Director, RMiC : Regenerative Medicine iPS Gateway Center Co., Ltd. (currently Repli-tech Co., Ltd.) (to present)
Feb. 2022	Director, TransMed, Inc. (to present)

Nobuo HANAI
Outside Director
Date of birth: Apr. 30, 1953

Career

Apr. 1976	Joined Kyowa Hakko Kogyo Co., Ltd.
Feb. 2003	President, BioWa, Inc.
Jun. 2006	Executive Officer, Kyowa Hakko Kogyo Co., Ltd.
Oct. 2008	Operating Director & Head of Development Dept., Kyowa Hakko Kirin Co., Ltd. (currently Kyowa Kirin Co., Ltd.）
Apr. 2009	Managing Executive Officer & Head of Development Dept., Kyowa Kirin Co., Ltd. (Kyowa Kirin)
Jun. 2009	Director & Senior Managing Executive Officer, Kyowa Kirin
Mar. 2010	Director & Executive Operating Officer, Kyowa Kirin
Mar. 2012	Executive Director, President & CEO, Kyowa Kirin
Mar. 2018	Executive Director, Chairman & CEO, Kyowa Kirin
Mar. 2019	Director & Chairman, Kyowa Kirin
May. 2020	Director, Leave a Nest Co., Ltd. (to present)
Jun. 2020	Outside Director, Shimadzu Corp. (to present)
Mar. 2021	Director, the Company (to present)
Jun. 2021	Outside Director, Aculys Pharma, Inc. (to present)
Oct. 2023	Outside Director, Hepalys Pharma, Inc. (to present)
Dec. 2023	Outside Director, Renalys Pharma, Inc. (to present)
Mar. 2024	Outside Director, Noile-Immune Biotech Inc. (to present)

Director, Audit & Supervisory Committee Member

Tatsuya NAGASE
Director, Full-time Audit & Supervisory Committee Member
Date of birth: Dec. 7, 1956

Career

Apr. 1981	Joined Kokusai Denshin Denwa Co., Ltd (currently KDDI CORPORATION)
Sep. 2000	Managing Director, KDDI Australia Pty Ltd
Apr. 2010	Internal Control Manager, Risk Management HQ, KDDI CORPORATION
Jul. 2011	Full-time Audit & Supervisory Board Member, Evolva Business Support, Inc. (currently Altius Link, Inc.)
Jul. 2013	Full-time Audit & Supervisory Board Member, KDDI Evolva Call Advance, Inc. (currently Altius Link, Inc.)
Apr. 2017	Audit & Supervisory Board Member, ARISE analytics Inc.
Jun. 2017	Audit & Supervisory Board Member, Japan Internet Exchange Co., Ltd.
Aug. 2017	Audit & Supervisory Board Member, SORACOM, INC.
Jul. 2019	Full-time Audit & Supervisory Board Member, CREEMA LTD.
Oct. 2019	Outside Audit & Supervisory Board Member, Japaniace Co., Ltd.　(to present)
May 2020	Full-time Outside Audit & Supervisory Board Member, GEOCODE CO.,Ltd.
Jun. 2022	Director, Audit & Supervisory Committee Member, the Company (to present)
Jun. 2023	Outside Audit & Supervisory Board Member, B dot Medical Inc. (to present)

Tadashi HORIUCHI
Outside Director, Audit & Supervisory Committee Member
Date of birth: Sep. 26, 1946

Career

Apr. 1972	Joined Daiichi Pharmaceutical Co., Ltd (currently Daiichi Sankyo Co., Ltd.)
Apr. 1989	Senior Researcher, Molecular Biology Laboratory, Daiichi Sankyo Co., Ltd. (Daiichi)
Oct. 1996	General Manager, Drug Discovery Research Laboratory, Daiichi
Oct. 1999	Corporate Officer & General Manager, Drug Discovery Research Laboratory, Daiichi
Apr. 2007	Standing Statutory Auditor, Asubio Pharma Co., Ltd. (currently Daiichi Sankyo Co., Ltd.)
Jul. 2008	Senior Coodinator, Center for Research Promotion, Comprehensive Research Promotion Organization, Keio University
Apr. 2016	Guest Professor, Clinical & Translational Research Center, Keio University Hospital (to present)
Sep. 2017	Science and Technical Advisor, Japan Agency for Medical Research and Development
Jun. 2019	Statutory Auditor, the Company
Jun. 2020	Director, Audit & Supervisory Committee Member, the Company (to present)

Takashi OHNO
Director, Audit & Supervisory Committee Member
Date of birth: Dec. 14, 1969

Career

Mar. 1996	Joined Showa Ota & Co. (currently Ernst & Young ShinNihon LLC)
Oct. 1998	Joined Asahi & Co. (currently KPMG AZSA LLC）
Apr. 2000	Registered as Certified Public Accountant
Apr. 2002	Registered as Certified Public Tax Accountant
Jan. 2006	Joined Ichiyoshi Securities Co., Ltd.
Feb. 2010	Joined CMIC Co., Ltd. (currently CMIC HOLDINGS Co., Ltd.)
Oct. 2016	Representative, Ohno Certified Public Accountant’s Office (to present)
Jun. 2021	Director, Audit & Supervisory Committee Member, the Company (to present)

CTO, Executive Officer

Tadashi MATSUURA
CTO, Executive Officer
Date of birth: Jan. 28, 1959

Career

Apr. 1988	Assistant, Shinshu University
Oct. 1992	Research Associate, Medical School, Dartmouth University
Oct. 1997	Researcher, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (currently The National Institute of Advanced Industrial Science and Technology)
Apr. 2002	HuBit genomix Inc. (HuBit genomix)
Apr. 2003	General Manager, Research and Development Dept., HuBit genomix
May 2005	Perseus Proteomics Inc. (the Company)
Feb. 2009	Head of Research and Development Dept., the Company
Jan. 2019	Executive Officer, the Company (to present)
Jun. 2019	Director, the Company
Jun. 2022	CTO, the Company (to present)

Advisors

Fuyuki Ishikawa
Vice President, Kyoto University; Director, Kyoto University Research Administration Center; Program Professor

Career

May 1982	Passed National Examination for Medical Practitioners
Jun. 1982	Resident, The University of Tokyo Hospital
Jun. 1983	Junior Resident, Jichi Medical University Hospital
Jun. 1984	Hematologist, The Third Dept. of Internal Medicine (Prof. F. Takahisa), The University of Tokyo
Oct. 1984	Research Associate, Carcinogenesis Division, National Cancer Center Research Institute
Apr. 1987	Assistant Professor, The Third Dept. of Internal Medicine, The University of Tokyo Hospital
May 1990	Ph. D (University of Tokyo)
Oct. 1990	Post Doctoral Fellow, Chemical & Biological Engineering Dept. (Prof. Thomas R. Cech), University of Colorado at Boulder
Oct. 1992	Associate Professor, School of Life Science and Technology, Dept. of Life Science and Technology, Tokyo Institute of Technology
Jan. 1998	Professor, School of Life Science and Technology, Dept. of Life Science and Technology, Tokyo Institute of Technology
Apr. 2002	Professor, Graduate School of Biostudies, Kyoto University
Oct. 2015	The 23rd Member, Secretary of Section II, Science Council of Japan
Oct. 2017	The 24th Member, Chairperson of Section II, Science Council of Japan 2019 President, The 78th Annual Meeting of the Japanese Cancer Association
Oct. 2022	Vice President, Kyoto University; Director, Kyoto University Research Administration Center;　Specially Appointed Professor
Mar. 2023	Emeritus Professor, Graduate School of Biostudies, Kyoto University
Apr. 2024	Vice President, Kyoto University; Director, Kyoto University Research Administration Center;　Program Professor (to present)

Kohei Tsumoto
Professor, School of Engineering, The University of Tokyo
Director, Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition

Career

Aug. 1995	Associate Professor, Tohoku University (Bioengineering, School of Engineering)
Aug. 2001	Lecturer, Tohoku University (Bioengineering, School of Engineering)
Oct. 2002	Assistant Professor, Tohoku University (Bioengineering, School of Engineering)
Mar. 2005	Assistant Professor, the University of Tokyo (Medical Genome, Graduate School of Frontier Sciences)
Apr. 2007	Associate Professor, the University of Tokyo (Medical Genome, Graduate School of Frontier Sciences)
May 2010	Professor, the University of Tokyo (Medical Proteomics Laboratory, The Institute of Medical Science) (to present)
Apr. 2013	Professor, the University of Tokyo (Dept. of Bioengineering, Dept. of Chemistry & Biotechnology, Graduate School of Engineering) (to present)
Apr. 2018	Advisor to President, the University of Tokyo (Administration, Research)
Apr. 2020	Executive Advisor to Director, Graduate School of Engineering (Planning)
Apr. 2021	Executive Advisor to President, the University of Tokyo (University Corporate Relations, Academic Excellence Enhancement) (to present)
Apr. 2023	Deputy Director, Graduate School of Engineering, the University of Tokyo (Education) (to present)

Yuji Kumagai
Emeritus Professor, Kitasato University

Career

Mar. 1989	Doctoral degree, Oita University Graduate School of Medicine
Apr. 1989	Assistant, Clinical Pharmacology, Jichi Medical University
Dec. 1991	Chronobiology, Medical School, University of Minnesota
Jul. 1995	Lecturer, Pharmacology, School of Medicine, Kitasato University
Apr. 2011	Professor, Kitasato Clinical Research Center
Apr. 2013	Director, Kitasato Clinical Research Center
Apr. 2023	Emeritus Professor, Kitasato University
Apr. 2023	Clinical Trial Advisor, Kitasato University Kitasato Institute Hospital